St. Louis, MO, United States of America

Charles F Zorumski

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1993-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Charles F Zorumski

Introduction

Charles F Zorumski is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of neuropharmacology, particularly in the development of neurosteroids and their applications in treating neurodegenerative conditions. With a total of 5 patents, Zorumski's work has garnered attention in both academic and medical circles.

Latest Patents

One of his latest patents focuses on "Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions." This patent describes a composition aimed at preventing or treating neurodegenerative conditions, which includes a neurosteroid, a synthetic enantiomer of a neurosteroid, or a combination of both. Another significant patent involves "Benz(epsilon)indene compounds," which are neuroactive benz[e]indene compounds prepared through total synthesis from specific starting materials.

Career Highlights

Zorumski is affiliated with Washington University, where he has been involved in groundbreaking research. His work has contributed to a deeper understanding of neuroactive compounds and their potential therapeutic effects. His innovative approaches have positioned him as a key figure in the field of neuropharmacology.

Collaborations

Throughout his career, Zorumski has collaborated with esteemed colleagues, including Douglas F Covey and Yuefei Hu. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Charles F Zorumski's contributions to the field of neuropharmacology through his patents and research at Washington University highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of neurodegenerative conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…